Carcinoid syndrome cost-effectiveness of therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Mahshid |
||
Line 14: | Line 14: | ||
[[Category:Pulmonology]] | [[Category:Pulmonology]] | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Gastroenterology]] | |||
[[Category:Endocrinology]] | |||
[[Category:Surgery]] |
Latest revision as of 02:39, 6 November 2017
Carcinoid syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Carcinoid syndrome cost-effectiveness of therapy On the Web |
American Roentgen Ray Society Images of Carcinoid syndrome cost-effectiveness of therapy |
Carcinoid syndrome cost-effectiveness of therapy in the news |
Risk calculators and risk factors for Carcinoid syndrome cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.